Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 5:06 pm Unchanged |
2024-12-31 | 13G | Protagenic Therapeutics, Inc. PTIX |
Armistice Capital, LLC | 240,000 3.410% |
0 (Unchanged) |
Filing History |
| 2024-11-14 5:19 pm Unchanged |
2024-09-30 | 13G | Protagenic Therapeutics, Inc. PTIX |
Armistice Capital, LLC | 240,000 5.100% |
0 (Unchanged) |
Filing History |
| 2024-02-14 2:29 pm Purchase |
2023-12-31 | 13G | Protagenic Therapeutics, Inc. PTIX |
Armistice Capital, LLC | 240,000 5.130% |
240,000 (New Position) |
Filing History |
| 2023-02-14 1:17 pm Unchanged |
2022-12-31 | 13G | Protagenic Therapeutics, Inc. PTIX |
Armistice Capital, LLC | 240,000 5.260% |
0 (Unchanged) |
Filing History |
| 2022-02-14 6:19 pm Purchase |
2021-12-31 | 13G | Protagenic Therapeutics, Inc. PTIX |
Armistice Capital, LLC | 240,000 5.400% |
240,000 (New Position) |
Filing History |
| 2022-02-04 4:29 pm Sale |
2021-12-31 | 13G | Protagenic Therapeutics, Inc. PTIX |
Hudson Bay Capital Management LP | 0 0.000% |
-273,243 (Position Closed) |
Filing History |
| 2021-02-10 3:43 pm Purchase |
2020-12-31 | 13G | Protagenic Therapeutics, Inc. PTIX |
Hudson Bay Capital Management LP | 273,243 9.990% |
2,749 (+1.02%) |
Filing History |